-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The IL-36 pathway plays a key role in the pathogenesis of generalized pustular psoriasis (GPP)
Investigators collected pre- and post-treatment skin and blood samples from GPP patients enrolled in a single-arm phase I study (n = 7)
immunity
As a result, 1287 transcripts were up- or down-regulated in GPP and PPP lesions
Taken together, our findings suggest that in GPP patients, spesolimab intervention rapidly modulates dysregulated molecular pathways commonly seen in GPP and PPP patients, which may be related to its ability to improve clinical outcomes in these patients
Original source:
Patrick Baum, et al.
Pustular psoriasis: Molecular pathways and effects of spesolimab in generalized pustular psoriasisLeave
a comment here